Asbjørn Mohr Drewes

Predictors of opioid efficacy in patients with chronic pain: A prospective multicenter observational cohort study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Kasper Grosen, Mech-Sense, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • ,
  • Anne E Olesen, Mech-Sense, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • ,
  • Mikkel Gram, Mech-Sense, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • ,
  • Torsten Jonsson, Valdemar Hospital, Ringsted, Denmark.
  • ,
  • Michael Kamp-Jensen, Valdemar Hospital, Ringsted, Denmark.
  • ,
  • Trine Andresen, Friklinikken, Region of Southern Denmark, Give, Denmark.
  • ,
  • Christian Nielsen, Friklinikken, Region of Southern Denmark, Give, Denmark.
  • ,
  • Gorazd Pozlep, Department of Anaesthetics and Surgical Intensive Care, Ljubljana University Medical Centre, Ljubljana, Slovenia.
  • ,
  • Mogens Pfeiffer-Jensen
  • Bart Morlion, Leuven Centre for Algology & Pain Management, University Hospitals Leuven, University Hospitals Leuven, Pellenberg, Belgium.
  • ,
  • Asbjørn M Drewes

Opioids are increasingly used for treatment of chronic pain. However, they are only effective in a subset of patients and have multiple side effects. Thus, studies using biomarkers for response are highly warranted. The current study prospectively examined 63 opioid-naïve patients initiating opioid use for diverse types of chronic pain at five European centers. Quantitative sensory testing, electroencephalography (EEG) recordings, and assessment of pain catastrophizing were performed prior to treatment. The co-primary outcomes were change from baseline in ratings of chronic pain and quality of life after 14 days of opioid treatment. Secondary outcomes included patient's global impression of clinical change and side effects. Logistic regression models adjusted for age and sex were used to identify biomarkers predictive for successful treatment, defined as at least a 30% reduction in average pain intensity or an improvement in quality of life of at least 10 scale points. Fifty-nine patients (94%) completed the study. The mean age was 55 ± 16 years and 69% were females. Pain reduction was predicted by cold pain intensity (OR: 0.69; P = 0.01), pain catastrophizing (OR: 0.82; P = 0.03), relative delta (OR: 0.76; P = 0.03) and beta EEG activity (OR: 1.18; P = 0.04) induced by experimental cold pain. None of the study variables were related to improvement in quality of life. For the first time, individual pain processing characteristics have been linked to opioid response in a mixed chronic pain population. This has the potential to personalize treatment of chronic pain and restrict opioid use to patients with high likelihood for response.

OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind12
Nummer2
Sider (fra-til)e0171723
ISSN1932-6203
DOI
StatusUdgivet - 3 feb. 2017

Se relationer på Aarhus Universitet Citationsformater

ID: 109088545